Amount Raised
$120 Million
Round Type
Series C
San DiegoBiotechnologyHealth CareTherapeuticsInvestors
Description
Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the closing of a $120 million Series C financing.
Quick answer
Escient Pharmaceuticals raised $120 Million in a Series C round, dated November 28, 2022. Investors: Altitude Life Science Ventures, Osage University Partners, Sanofi Ventures, Cowen Healthcare Investments, 5 Am Ventures, The Eleven Fund and Forge Life Science Partners. Escient Pharmaceuticals is based in San Diego, California, United States.
- How much did Escient Pharmaceuticals raise?
- Escient Pharmaceuticals raised $120 Million in a Series C round on November 28, 2022.
- Who invested in Escient Pharmaceuticals?
- Altitude Life Science Ventures, Osage University Partners, Sanofi Ventures, Cowen Healthcare Investments, 5 Am Ventures, The Eleven Fund and Forge Life Science Partners are named as investors in this round.
- What does Escient Pharmaceuticals do?
- Escient Pharmaceuticals is a clinical-stage company focused on developing novel therapeutics to address a broad range of neurosensory-inflammatory disorders.
- Where is Escient Pharmaceuticals based and how big is it?
- Escient Pharmaceuticals is based in San Diego, California, United States.
- Who are the decision-makers at Escient Pharmaceuticals?
- Fundz holds 1 contact at Escient Pharmaceuticals, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Escient Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
- Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
- Inotrem raised an undisclosed amount (Funding Round) on January 9, 2023.
- Synthekine raised $100M (Series C) on January 6, 2023.
- HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
- Immune-Onc Therapeutics raised an undisclosed amount (Series B) on January 5, 2023.
Who to call at Escient Pharmaceuticals, and when
A new round usually means Escient Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Escient Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Escient Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Escient Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Escient Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Escient Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.